Michael Comstock

Davis Polk advised Charles River Laboratories International, Inc. in connection with its Rule 144A/Regulation S offering of $500 million aggregate principal amount of 4.250% senior notes…

Davis Polk advised the joint book-running managers on an SEC-registered offering by LYB International Finance III, LLC, a wholly owned subsidiary of LyondellBasell Industries N.V., of $1…

Davis Polk advised the joint book-running managers on an SEC-registered offering by LYB International Finance II B.V., a wholly owned subsidiary of LyondellBasell Industries N.V., of €500…

Davis Polk advised the initial purchasers on a Rule 144A/Regulation S offering by YUM! Brands, Inc. of $800 million aggregate principal amount of 4.75% senior notes due 2030. Proceeds from…

Davis Polk acted as counsel to the underwriter, forward seller and forward purchaser in connection with the execution of a forward sale agreement with HL1 17 LP (the “Selling Shareholder”),…

Davis Polk advised the book-running manager on an SEC-registered offering by Mohawk Capital Finance S.A. of floating-rate notes due 2021. The notes are fully and unconditionally…

Davis Polk advised Freeport-McMoRan Inc. (“FCX”) in connection with its SEC-registered offering of $1.2 billion of senior notes. The offering consisted of two tranches of senior notes,…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a public offering by PPG Industries, Inc. of $300 million…

Davis Polk advised the underwriter, forward seller and forward purchaser in connection with the execution of a forward sale agreement with HL1 17 LP (the “Selling Shareholder”), an…

Davis Polk is advising the Goldman Sachs Merchant Banking Division in connection with its investment in MedVet. Founded in 1869, The Goldman Sachs Group, Inc. is a leading global investment…